Combination of Local Ablative Therapy and Continuation of Immune Checkpoint Inhibitor (ICI) Therapy Provides Durable Treatment Response Past Oligometastatic Progression in NSCLC: A Case Report
| Publication | Article in Case Reports in Oncology, published November 2019 |
|---|---|
| Authors | Cassia R. Griswold, Katie Kerrigan, Shiven B. Patel |
This is the public page for a publication record in Dimensions, a free research insights platform that brings together information about funding, scholarly outputs, policy, patents and grants.
Loading metrics…